Mörike K - Search Results

1

Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model.

Abduljalil K, Lazar S, Natanzon M, Wu W, Zadoyan G, Steffens B, Kohl V, Mörike K, Tomalik-Scharte D, Stingl J, Schwab M, Harenberg J, Gleiter C, Fuhr U. Abduljalil K, et al. Among authors: morike k. Clin Pharmacokinet. 2013 May;52(5):359-71. doi: 10.1007/s40262-013-0043-z. Clin Pharmacokinet. 2013. PMID: 23519598 Clinical Trial.

2

Clinical pharmacokinetics of candesartan.

Gleiter CH, Mörike KE. Gleiter CH, et al. Clin Pharmacokinet. 2002;41(1):7-17. doi: 10.2165/00003088-200241010-00002. Clin Pharmacokinet. 2002. PMID: 11825094 Review.

3

Ginger-associated overanticoagulation by phenprocoumon.

Krüth P, Brosi E, Fux R, Mörike K, Gleiter CH. Krüth P, et al. Among authors: morike k. Ann Pharmacother. 2004 Feb;38(2):257-60. doi: 10.1345/aph.1D225. Epub 2003 Dec 19. Ann Pharmacother. 2004. PMID: 14742762 Review.

4

Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study.

Dilger K, Fux R, Röck D, Mörike K, Gleiter CH. Dilger K, et al. Among authors: morike k. J Clin Pharmacol. 2007 Dec;47(12):1532-9. doi: 10.1177/0091270007308617. J Clin Pharmacol. 2007. PMID: 18048573 Clinical Trial.

5

No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidine.

Böhmer GM, Gleiter CH, Mörike K, Nassr N, Walz A, Lahu G. Böhmer GM, et al. Among authors: morike k. J Clin Pharmacol. 2011 Apr;51(4):594-602. doi: 10.1177/0091270010368282. Epub 2010 May 19. J Clin Pharmacol. 2011. PMID: 20484614

6

Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.

Lutz M, Schwab M, Griese EU, Marx C, Müller-Oerlinghausen B, Schönhöfer PS, Meisner C, Gleiter CH, Eichelbaum M, Mörike K. Lutz M, et al. Among authors: morike k. Pharmacogenetics. 2002 Jan;12(1):73-5. doi: 10.1097/00008571-200201000-00010. Pharmacogenetics. 2002. PMID: 11773867

7

Off label prescribing to children in primary care in Germany: retrospective cohort study.

Bücheler R, Schwab M, Mörike K, Kalchthaler B, Mohr H, Schröder H, Schwoerer P, Gleiter CH. Bücheler R, et al. Among authors: morike k. BMJ. 2002 Jun 1;324(7349):1311-2. doi: 10.1136/bmj.324.7349.1311. BMJ. 2002. PMID: 12039825 Free PMC article. No abstract available.

8

Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Mörike K, Schwab M, Klotz U. Mörike K, et al. Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003. Drugs Aging. 1997. PMID: 9108987 Review.

9

Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor.

Bethke TD, Böhmer GM, Hermann R, Hauns B, Fux R, Mörike K, David M, Knoerzer D, Wurst W, Gleiter CH. Bethke TD, et al. Among authors: morike k. J Clin Pharmacol. 2007 Jan;47(1):26-36. doi: 10.1177/0091270006294529. J Clin Pharmacol. 2007. PMID: 17192499 Clinical Trial.

10

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.

Fux R, Mörike K, Pröhmer AM, Delabar U, Schwab M, Schaeffeler E, Lorenz G, Gleiter CH, Eichelbaum M, Kivistö KT. Fux R, et al. Among authors: morike k. Clin Pharmacol Ther. 2005 Oct;78(4):378-87. doi: 10.1016/j.clpt.2005.07.004. Clin Pharmacol Ther. 2005. PMID: 16198657 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page